Literature DB >> 8527392

Localization of metastasis suppressor gene(s) for rat prostatic cancer to the long arm of human chromosome 10.

N Nihei1, T Ichikawa, Y Kawana, H Kuramochi, H Kugo, M Oshimura, A M Killary, C W Rinker-Schaeffer, J C Barrett, J T Isaacs.   

Abstract

To examine the role of human chromosome 10 in development of prostatic cancer, we introduced human chromosome 10 into highly metastatic rat prostatic cancer cells by microcell-mediated chromosome transfer. Microcell hybrid cells introduced with human chromosome 10 showed suppression of the metastatic ability to the lung to some extent without any suppression of tumorigenicity, although the tumor growth rate decreased slightly. To minimize the region that contains metastasis suppressive activity, the hybrid cells in metastasis foci of lung were established in culture and reanalyzed for portions of human chromosome 10 retained in the metastasis tissues. Cytogenetic and molecular analyses demonstrated that loss of the region between 10cen and D10S215 on human chromosome arm 10q was related to expression of the metastatic phenotype. These results demonstrate that the region between 10cen and D10S215 on human chromosome arm 10q contains at least one of the metastasis suppressor genes for rat prostatic cancer.

Entities:  

Mesh:

Year:  1995        PMID: 8527392     DOI: 10.1002/gcc.2870140205

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  8 in total

1.  RIG-I helicase-independent pathway in sendai virus-activated dendritic cells is critical for preventing lung metastasis of AT6.3 prostate cancer.

Authors:  Tomonori Kato; Yasuji Ueda; Hiroaki Kinoh; Yasuo Yoneyama; Akinao Matsunaga; Atsushi Komaru; Yui Harada; Hiroyoshi Suzuki; Akira Komiya; Satoko Shibata; Mamoru Hasegawa; Hideki Hayashi; Tomohiko Ichikawa; Yoshikazu Yonemitsu
Journal:  Neoplasia       Date:  2010-11       Impact factor: 5.715

Review 2.  Molecular markers for prostate cancer metastasis. Developing diagnostic methods for predicting the aggressiveness of prostate cancer.

Authors:  J T Isaacs
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

3.  Expression of the KAI1 protein in benign prostatic hyperplasia and prostate cancer.

Authors:  T Ueda; T Ichikawa; J Tamaru; A Mikata; K Akakura; S Akimoto; T Imai; O Yoshie; T Shiraishi; R Yatani; H Ito; J Shimazaki
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

4.  Dr. Coffey's visionary contributions to urological research in China and Japan.

Authors:  Jun Shimazaki; Leland Wk Chung; Haiyen E Zhau; Tomohiko Ichikawa
Journal:  Am J Clin Exp Urol       Date:  2018-04-01

Review 5.  Genomics screens for metastasis genes.

Authors:  Jinchun Yan; Qihong Huang
Journal:  Cancer Metastasis Rev       Date:  2012-12       Impact factor: 9.264

Review 6.  Prostate cancer--biology of metastasis and its clinical implications.

Authors:  J T Dong; C W Rinker-Schaeffer; T Ichikawa; J C Barrett; J T Isaacs
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

Review 7.  Metastasis suppressor genes.

Authors:  Jinchun Yan; Qin Yang; Qihong Huang
Journal:  Histol Histopathol       Date:  2013-03       Impact factor: 2.303

8.  Normal viability of Kai1/Cd82 deficient mice.

Authors:  John I Risinger; Mary Custer; Lionel Feigenbaum; R Mark Simpson; Shelley B Hoover; Joshua D Webster; Gadisetti V R Chandramouli; Lino Tessarollo; J Carl Barrett
Journal:  Mol Carcinog       Date:  2013-02-08       Impact factor: 4.784

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.